D'Angelo C - Search Results

1

Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis.

Salvati E, Zizza P, Rizzo A, Iachettini S, Cingolani C, D'Angelo C, Porru M, Randazzo A, Pagano B, Novellino E, Pisanu ME, Stoppacciaro A, Spinella F, Bagnato A, Gilson E, Leonetti C, Biroccio A. Salvati E, et al. Nucleic Acids Res. 2014 Mar;42(5):2945-57. doi: 10.1093/nar/gkt1289. Epub 2013 Dec 11. Nucleic Acids Res. 2014. PMID: 24335081 Free PMC article.

2

Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.

Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D'Angelo C, Sacchi A, Zupi G. Del Bufalo D, et al. J Clin Invest. 1996 Sep 1;98(5):1165-73. doi: 10.1172/JCI118900. J Clin Invest. 1996. PMID: 8787680 Free PMC article.

3

Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.

Biroccio A, Bufalo DD, Ricca A, D'Angelo C, D'Orazi G, Sacchi A, Soddu S, Zupi G. Biroccio A, et al. Gene Ther. 1999 Jun;6(6):1064-72. doi: 10.1038/sj.gt.3300935. Gene Ther. 1999. PMID: 10455409

4

c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Biroccio A, Benassi B, D'Agnano I, D'Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B, Zupi G. Biroccio A, et al. Am J Pathol. 2001 Apr;158(4):1289-99. doi: 10.1016/S0002-9440(10)64080-1. Am J Pathol. 2001. PMID: 11290547 Free PMC article.

5

In vivo administration of liposomal vincristine sensitizes drug-resistant human solid tumors.

Leonetti C, Scarsella M, Semple SC, Molinari A, D'Angelo C, Stoppacciaro A, Biroccio A, Zupi G. Leonetti C, et al. Int J Cancer. 2004 Jul 10;110(5):767-74. doi: 10.1002/ijc.20174. Int J Cancer. 2004. PMID: 15146568

6

Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.

Leonetti C, Amodei S, D'Angelo C, Rizzo A, Benassi B, Antonelli A, Elli R, Stevens MF, D'Incalci M, Zupi G, Biroccio A. Leonetti C, et al. Mol Pharmacol. 2004 Nov;66(5):1138-46. doi: 10.1124/mol.104.001537. Epub 2004 Aug 10. Mol Pharmacol. 2004. PMID: 15304549

7

Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to Trastuzumab.

Biroccio A, D'Angelo C, Jansen B, Gleave ME, Zupi G. Biroccio A, et al. J Cell Physiol. 2005 Aug;204(2):463-9. doi: 10.1002/jcp.20295. J Cell Physiol. 2005. PMID: 15685647

8

Potentiation of the antitumoral activity of gemcitabine and paclitaxel in combination on human breast cancer cells.

Zupi G, Scarsella M, D'Angelo C, Biroccio A, Paoletti G, Lopez M, Leonetti C. Zupi G, et al. Cancer Biol Ther. 2005 Aug;4(8):866-71. doi: 10.4161/cbt.4.8.1895. Cancer Biol Ther. 2005. PMID: 16210917

9

Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint.

Bruno T, De Nicola F, Iezzi S, Lecis D, D'Angelo C, Di Padova M, Corbi N, Dimiziani L, Zannini L, Jekimovs C, Scarsella M, Porrello A, Chersi A, Crescenzi M, Leonetti C, Khanna KK, Soddu S, Floridi A, Passananti C, Delia D, Fanciulli M. Bruno T, et al. Cancer Cell. 2006 Dec;10(6):473-86. doi: 10.1016/j.ccr.2006.10.012. Cancer Cell. 2006. PMID: 17157788 Free article.

10

Therapeutic integration of c-myc and bcl-2 antisense molecules with docetaxel in a preclinical model of hormone-refractory prostate cancer.

Leonetti C, Biroccio A, D'Angelo C, Semple SC, Scarsella M, Zupi G. Leonetti C, et al. Prostate. 2007 Sep 15;67(13):1475-85. doi: 10.1002/pros.20636. Prostate. 2007. PMID: 17654511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters